1257409-46-3

Upstream product

• 1257409-45-2 ethyl [4-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-3-(4-chlorobenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]acetate 

Downstream Products

• 1257409-48-5 4-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-5-(4-chlorobenzyl)-2-[(5-sulfanyl-1,3,4-oxadiazol-2-yl)methyl]-2,4-dihydro-3H-1,2,4-triazole-3-one 
• 1257409-49-6 2-{[4-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-yl)-3-(4-chlorobenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazole-1-yl]acetyl}-N-benzylhydrazinecarbothioamide 
• 1257409-52-1 2-{[4-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-yl)-3-(4-chlorobenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazole-1-yl]acetyl}-N-(4-fluorophenyl)hydrazinecarbothioamide 

Relevant academic research and scientific papers

Cyclization of some carbothioamide derivatives containing antipyrine and triazole moieties and investigation of their antimicrobial activities

Acetohydrazide derivative containing both antipyrine and triazole nuclei (5) was obtained starting from ethyl hydrazinecarboxylate derivative (2) and 4-aminoantipyrine (1) by three steps. The treatment of compound 5 with CS 2 afforded the conve